A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

July 2, 2025

Study Completion Date

July 2, 2025

Conditions

Pain

Interventions

DRUG

HRS-2129

HRS-2129.

DRUG

HRS-2129 placebo

HRS-2129 placebo.

Trial Locations (1)

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06742840 - A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects | Biotech Hunter | Biotech Hunter